Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.
Gao W, Zhang Y, Luo H, Niu M, Zheng X, Hu W, Cui J, Xue X, Bo Y, Dai F, Lu Y, Yang D, Guo Y, Guo H, Li H, Zhang Y, Yang T, Li L, Zhang L, Hou R, Wen S, An C, Ma T, Jin L, Xu W, Wu Y.
Gao W, et al. Among authors: wu y.
Cell Death Dis. 2020 Oct 26;11(10):919. doi: 10.1038/s41419-020-03104-6.
Cell Death Dis. 2020.
PMID: 33106477
Free PMC article.